TESTATE STI project: an online chlamydia and gonorrhoea self-sampling strategy for gay, bisexual and other men who have sex with men and trans people in Catalonia (Spain)
Martínez-Riveros et al.
The finding, in our words
An online self-sampling intervention for chlamydia and gonorrhoea using urine kits achieved a 20.7% positivity rate, with 90% of infections being extragenital, and linked 81% of positive cases to treatment, indicating high acceptability and feasibility for decentralised STI testing.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
Urine testing for high-risk HPV achieved 86.2% sensitivity for detecting high-grade cervical lesions, slightly below the 94.8% sensitivity of cervical samples, while patient satisfaction was significantly higher with self-collected urine. High agreement for HPV 16/18 genotypes between the two methods supports urine as a viable alternative for decentralised cervical screening.
Urine self-sampling for HPV detection showed good agreement with clinician-collected cervical samples (Kappa 0.72) under optimised conditions of 40 mM EDTA preservative, storage at 25°C, and processing within 72 hours. With a cost of USD 1.10 and high acceptability among women and healthcare workers, this method offers a practical decentralised screening approach for resource-limited settings.
At-home first-void urine self-collection with Colli-Pee was feasible, well accepted, and gave chlamydia/gonorrhoea detection comparable to routine clinic-based urine, supporting home first-void sampling for populations needing frequent STI testing.
A study of 2500 women found 99.0% agreement between first-void urine and vaginal self-sampling for HPV detection using Cobas4800, with 98.1% of participants preferring urine. Although conducted in a resource-limited setting which may limit generalisability, these results support urine as a viable sample type for decentralised, patient-centric screening.
First-void urine and self-collected vaginal swabs showed similar sensitivity and specificity to clinician-collected cervical samples for high-risk HPV detection across two real-time PCR assays, supporting their use as decentralised, patient-collected alternatives; most women preferred first-void urine for regular cervical screening.